Neuro-Oncology

Top Story

FDA grants breakthrough therapy designation to Azedra for pheochromocytoma, paraganglioma

July 28, 2015

The FDA granted breakthrough therapy designation to Ultratrace iobenguane I-131 for the treatment of patients with iobenguane-avid metastatic or recurrent pheochromocytoma and paraganglioma, according to a press release from the drug’s manufacturer.

Ultratrace iobenguane I-131 (Azedra, Progenics Pharma), a late-state radiotherapeutic drug candidate, is being evaluated in a phase 2b trial of patients with malignant pheochromocytoma or paraganglioma. Pheochromocytomas — rare tumors usually found within one or both adrenal glands — are referred to as paragangliomas when they arise in other areas of sympathetic nerve cells.

FDA News

FDA grants orphan drug designation to Ad-RTS-hIL-12 for malignant glioma

July 24, 2015
The FDA today granted orphan drug designation to Adenoviral vector-RheoSwitch Therapeutic System-human interleukin 12 + veledimex, or Ad-RTS-hIL-12,  for the…

What are symptoms of cancer in children?

July 17, 2015
Cancer is a difficult disease to detect in children, as symptoms may be minimal or even nonexistent.Cancer is the second leading cause of death among those aged younger…
FDA News

FDA grants orphan drug designation to Anisina for neuroblastoma

July 16, 2015
The FDA granted orphan drug designation to the chemotherapy drug Anisina for the treatment of pediatric patients with neuroblastoma, according to a press release from…
CME
Hematology Oncology Case Consults

The Patient with Melanoma

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with melanoma.
More »
CME
Immunotherapy Updates 2015: FOCUS on NSCLC

Immunotherapy Updates 2015: FOCUS on NSCLC

This activity is supported by educational grants from Genentech, Inc. and Merck & Co., Inc.

Globally, lung cancer is the leading cause of cancer-related deaths. Non-small cell lung cancer (NSCLC) accounts for…
More »
FDA News

FDA grants breakthrough therapy designation to Azedra for pheochromocytoma, paraganglioma

July 28, 2015
The FDA granted breakthrough therapy designation to Ultratrace iobenguane I-131 for the treatment of patients with iobenguane-avid metastatic or…
FDA News

FDA grants orphan drug designation to Ad-RTS-hIL-12 for malignant glioma

July 24, 2015
The FDA today granted orphan drug designation to Adenoviral vector-RheoSwitch Therapeutic System-human interleukin 12 + veledimex, or Ad-RTS-hIL-12…

What are symptoms of cancer in children?

July 17, 2015
Cancer is a difficult disease to detect in children, as symptoms may be minimal or even nonexistent.Cancer is the second leading cause of death among…
FDA News

FDA grants orphan drug designation to Anisina for neuroblastoma

July 16, 2015
The FDA granted orphan drug designation to the chemotherapy drug Anisina for the treatment of pediatric patients with neuroblastoma, according to a…
FDA News

FDA grants orphan drug designation to BLZ-100 for brain cancer

July 7, 2015
The FDA granted orphan drug designation to BLZ-100, an agent intended to improve surgery for malignant brain tumors by providing real-time…
Meeting News Coverage

Top Takeaways from ASCO: Neuro-oncology

July 3, 2015
CHICAGO  – Neuro-oncologists were buoyed by findings revealed within their subspecialty at ASCO 2015, with potentially practice-changing…
In the JournalsPerspective

Genomic data may better classify lower-grade glioma than histology

June 30, 2015
IDH, 1p/19q and TP53 status more accurately represented three molecular classes of lower-grade gliomas than histologic class, according to study…
Paula T. Rieger RN, MSN, CAE, FAAN Meeting HighlightsPublication Exclusive

Oncology nurses showcase ‘passion for excellence’ at 40th ONS Congress

HemOnc Today, June 25, 2015
Paula T. Rieger, RN, MSN, CAE, FAAN
The Oncology Nursing Society 40th Annual Congress brought together more than 3,000 nurses with a passion for excellence in the care they provide, as…
In the Journals

Promoter mutations redefine molecular subgroups of gliomas

June 17, 2015
Gliomas can be classified into five distinct categories based on the presence of IDH, 1p/19q codeletion and TERT promoter mutations, according to…
In the Journals

Anticoagulants safe for patients with brain metastases

June 9, 2015
The use of anticoagulant medication did not increase the risk for intracranial hemorrhage among cancer patients with brain metastases, according to…
More Headlines »
morganatic-roan
morganatic-roan